Hemispherx Biopharma, Inc. (AMEX: HEB) announced that effective July 23, 2013, the Board of Directors of Hemispherx approved the appointment ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE